A Randomized Cross Over Trial Of Tolerability And Compliance Of A Supplement With Low Iron Separated From Calcium Versus High Iron Combined With Calcium In Pregnant Wome

Not Applicable

Completed

• Conditions: Pregnancy; Pregnancy and Childbirth; Nutritional supplementation

• Registration Number: ISRCTN56071145
• Lead Sponsor: Duchesnay Inc (Canada)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-11-01
• Last Update Posted: 30 October 2017

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Pregnant women between 18 and 45 years of age.

Exclusion Criteria

1. Pregnant women with insufficient English language skills to understand the questions
2. Pregnant women who refuse to participate in our study
3. Chronic illness
4. Current acute illness and known allergies to either Materna or PregVit

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare the tolerability and adverse effects of PregVit versus Materna.

Secondary Outcome Measures

Name	Time	Method
A comparison of patients’ compliance measured by pill counts of PregVit versus Materna